Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Level Office puts coworking space on tap in former law building (Photos)
Windows from the community coworking space in Level Office’s seven-floor Kessler Building offer an up-close view of the Jackson County Courthouse, Sprint Center and downtown Kansas City. That proximity to the 16th Circuit Court, the court of appeals and the Jackson County Detention Center makes Chicago-based Level Office a magnet for men and women in…
Former Netchemia CEO, KC venture capitalist launch new fund for Midwest software firms
Keith Harrington isn’t looking for hockey-stick growth companies. With the new fund he’s co-leading — Novel Growth Partners — Harrington wants to invest in small, steadily-growing tech companies in the Midwest. But instead of a traditional venture capital model, Novel is employing a revenue-based finance model that should appeal to more entrepreneurs, Harrington said. “We believe that…
1 Million Cups celebrating black startups with all black founders, experts in February
A lineup of all black presenters and experts at February’s 1 Million Cups events aims for exposure and awareness about Kansas City’s thriving community of black entrepreneurs, said Adrienne Haynes. “Many of these companies are not necessarily tech-based. They might not be at Plexpod or WeWork. Many of them have their own facilities — maybe…
Listen: Behind the scenes interview with Hyperloop One exec on Missouri plan
By now you’ve likely seen that Missouri is a top five favorite to land a Virgin Hyperloop One route. If built in Missouri, the tubular transportation system would move people from Kansas City to St. Louis in 30 minutes, creating a mega-region that combines the state’s biggest cities, said Dan Katz, director of global public…